参竹心康汤抗心衰大鼠心肌纤维化的实验研究Study on the Mechanism of Shenzhu Xinkang Decoction Against Myocardial Fibrosis in Rats with Heart Failure
成笑楠;喻正科;赵文博;李玉莹;
摘要(Abstract):
目的 观察参竹心康汤对微小核糖核酸-21(miRNA-21)/磷酸酯酶与张力蛋白同源物(PTEN)及内皮间质转化(End MT)的影响,探讨其抗心力衰竭心肌纤维化的分子机制。方法 SD大鼠55只,随机抽取10只为假手术组,45只为造模组。造模成功后分为模型组、卡托普利组、参竹心康汤组。假手术组和模型组给蒸馏水10 mL/kg,卡托普利组给蒸馏水+卡托普利7.8 mg/kg,参竹心康汤组给蒸馏水+参竹心康汤44 g/kg。给药6周后采用Masson染色法观察心肌形态结构、RT-PCR法检测心肌组织miRNA-21的表达、Western blotting检测心肌PTEN蛋白表达、免疫荧光法检测心肌组织CD31、α-SMA的表达。结果 与假手术组比较,模型组大鼠心肌纤维化明显,心肌组织PTEN、CD31的表达显著减少(P <0.01),miRNA和α-SMA表达显著增加(P <0.01);与模型组比较,参竹心康汤组、卡托普利组上述指标逆转(P <0.05或P <0.01);与卡托普利组比,参竹心康汤组PTEN蛋白表达显著升高(P <0.01),miRNA表达显著下降(P <0.01),参竹心康汤组和卡托普利组在CD31上差异明显(P <0.05)。结论 参竹心康汤可能通过调控miRNA-21/PTEN抑制内皮间质转化,从而抑制心肌纤维化,治疗心力衰竭。
关键词(KeyWords): 心力衰竭;心肌纤维化;参竹心康汤;miRNA-21/PTEN;内皮间质转化;大鼠
基金项目(Foundation): 湖南省自然科学基金项目(2019JJ80069)
作者(Authors): 成笑楠;喻正科;赵文博;李玉莹;
参考文献(References):
- [1]喻正科,朱筱婧,陈志红,等.参竹心康汤对心衰患者的临床疗效及血管内皮功能的影响[J].湖南中医药大学学报,2012,32(11):54-57.
- [2] Golomb BA,Verden A,Messner AK,et al. Amyotrophic lateral sclerosis associated with statin use:A disproportionality analysis of the FDA′s adverse event reporting system[J].Drug Saf,2018,41(4):403-413.
- [3]喻正科,陈志红,颜旭,等.参竹心康汤对慢性心力衰竭大鼠心室重构的影响[J].中国中医急症,2013,22(2):205-207,223.
- [4]侯剑辉,叶博然,刘钰君,等.大鼠慢性充血性心力衰竭模型的建立与评价[J].现代医院,2012,12(4):26-28.
- [5]喻正科,曹丕钢,陈志红,等.参竹心康汤对慢性心力衰竭大鼠心肌纤维化及心肌MMP-9、TIMP-1的影响[J].中医药导报,2016,22(5):29-33.
- [6]喻正科,曹丕钢,陈志红,等.参竹心康汤对慢性心衰大鼠心肌纤维化及TGF-β_1、CTGF表达的影响[J].中华中医药学刊,2015,33(9):2169-2171.
- [7]邱羽菲,史嘉翊,宋旭东,等.心肌纤维化的发生机制及治疗研究进展[J].心脏杂志,2021,33(5):553-557.
- [8]邱浚,周建庆.内皮-间质转化与心血管疾病的研究进展[J].浙江医学,2021,43(5):559-562.
- [9] Xu-Dubois Y C,Peltier J,Brocheriou I,et al. Markers of endothelial-to-mesenchymal transition:Evidence for antibodyendothelium interaction during antibody-mediated rejection in kidney recipient[J]. J Am Soc Nephrol,2016,27(1):324-332.
- [10] Zeisberg EM,Tarnavski O,Zeisberg M,et al. Endothelial tomesenchymal transition contributes to cardiac fibrosis[J].NatMed,2007,13(8):952-961.
- [11] Chen X,Ge W,Hu J,et al. Inhibition of prostaglandin E2 respector 4 by Inc000908 to promote the endothelial-mesenchymal transition participation in cardiac remodelling[J]. J Cell Mol Med,2019,23(9):6355-6367.
- [12] Dong S,Ma W,Hao B,et al. MicroRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2[J]. Clin Exp Pathol,2014,7(2):565-574.
- [13] Verjans R,Peters T,Beaumont FJ,et al. MicroRNA-221/222family counteracts myocardial fibrosis in pressure overloadinduced heart failure[J]. Hypertension,2017,71(2):117.
- [14]李晓怡,卢忠心. miRNA与心血管疾病研究进展[J].国际检验医学杂志,2014,33(21):2912-2914.
- [15]刘凯,钱源源,张璘,等. PTEN基因与纤维化疾病[J].卫生研究,2020,49(6):1038-1044.
- [16] Oudit GY,Penninger JM. Cardiac regulation by phosphoinositide 3-kinases and PTEN[J]. Cardiovasc Res,2009,82(2):250-260.
- [17] Thum T,Gross C,Fiedler J,et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts[J]. Nature,2008,456(7224):980-984.
- [18] Kumarswamy R,Volkmann I,Jazbutyte V,et al. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21[J]. Arterioscler Thromb Vasc Biol,2012,3(2):361-369.
- [19]朱晓雨,王洪新,李佳莘,等.黄芪多糖对大鼠心肌纤维化的保护作用[J].沈阳药科大学学报,2017,34(8):686-693.
- [20]王国钦,李瑞满,金伟,等.麦冬抑制大鼠心肌成纤维细胞胶原合成的作用及其机制[J].中国病理生理杂志,2013,29(4):615-618.
- [21]李湘海,向凝.丹参素对急性心肌梗死大鼠心肌纤维化的影响[J].中药材,2020,43(2):473-477.
- [22]康玲玲,高端敏.三七皂苷R1对心房颤动大鼠心肌炎症相关因子和金属基质蛋白酶表达的影响[J].中山大学学报:医学版,2019,40(6):921-929.